MedTrace Logo

The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)

NCT04356365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10084

Last updated 2020-04-24

No results posted yet for this study

Summary

This study seeks to investigate the levels of common psychopathology symptoms (i.e., depression and generalized anxiety) in a general population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic. The study also seeks to examine the predictors of generalized anxiety and depressive symptoms, as well as predictors of adherence rates to government-initiated non-pharmacological epidemiological interventions (NPI's).

The aim of the project is to:

* Inform the policymakers, the general public, scientists, and health practitioners about the psychological associations of the COVID-19-related government-initiated measures.
* Provide a foundation for policymakers and health-care professionals to employ interventions that protect the general public against possibly increased psychological stressors, suffering and dysfunction during society's handling of the pandemic.
* Help policymakers better understand the associations of demographic variables and psychological symptoms with adherence, providing an initial understanding of adherence rates, which may be used to help society fight against the COVID-19-virus from an epidemiological perspective by promoting factors that increase adherence.

Conditions

  • Depression
  • Generalized Anxiety
  • Adherence to Non-pharmacological Epidemiological Interventions (NPIs)

Interventions

OTHER

Cross-sectional study investigating the association of NPIs with mental health

Cross-sectional study investigating the association of NPIs with mental health

Sponsors & Collaborators

  • Modum Bad

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Omid V. E Ebrahimi, Double PhD Candidate · University of Oslo

  • Asle Hoffart, PhD · Professor at University of Oslo

  • Sverre Urnes Johnson, PhD · Associate Professor at University of Oslo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2020-04-07
Completion
2020-04-07

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04356365 on ClinicalTrials.gov